Highly Pathogenic H5N1 Influenza A Virus Strains Provoke Heterogeneous IFN-α/β Responses That Distinctively Affect Viral Propagation in Human Cells

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Matthaei, Markus ^a,b   Budt, Matthias ^a   Wolff, Thorsten ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; NONSTRUCTURAL PROTEIN 1; RETINOIC ACID INDUCIBLE PROTEIN I;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE ACTIVATION; GENE MUTATION; GENE REPRESSION; GENETIC HETEROGENEITY; GENETIC REGULATION; HOST; HUMAN; HUMAN CELL; IFN ALPHA GENE; IFN BETA GENE; INFLUENZA A (H5N1); INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN INDUCTION; VIROGENESIS; VIRUS GENE; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; BIRDS; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOBLOTTING; INFLUENZA A VIRUS, H5N1 SUBTYPE; INTERFERON-ALPHA; INTERFERON-BETA; VIRUS REPLICATION;

EID: 84874508078     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056659     Document Type: Article

References (101)

1. Wright PF, Neumann G. (2007) Orthomyxoviruses. Fields Virology. 5 ed. Philadelphia: Lippincott Williams & Wilkens. 1691-1740.
2. Neumann G, Noda T, Kawaoka Y, (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
3. Kawaoka Y, Krauss S, Webster RG, (1989) Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 63: 4603-4608.
4. Scholtissek C, Rohde W, Von Hoyningen V, Rott R, (1978) On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87: 13-20.
5. Kalthoff D, Globig A, Beer M, (2010) (Highly pathogenic) avian influenza as a zoonotic agent. Vet Microbiol 140: 237-245.
6. Maines TR, Szretter KJ, Perrone L, Belser JA, Bright RA, et al. (2008) Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev 225: 68-84.
7. Connor RJ, Kawaoka Y, Webster RG, Paulson JC, (1994) Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205: 17-23.
8. Gambaryan A, Tuzikov A, Pazynina G, Bovin N, Balish A, et al. (2006) Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology 344: 432-438.
9. Stevens J, Blixt O, Chen LM, Donis RO, Paulson JC, et al. (2008) Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J Mol Biol 381: 1382-1394.
10. Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, et al. (2006) Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444: 378-382.
11. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, et al. (2007) Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 13: 147-149.
12. Oshansky CM, Pickens JA, Bradley KC, Jones LP, Saavedra-Ebner GM, et al. (2011) Avian influenza viruses infect primary human bronchial epithelial cells unconstrained by sialic acid alpha2,3 residues. PLoS One 6: e21183.
13. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, et al. (2006) Avian flu: influenza virus receptors in the human airway. Nature 440: 435-436.
14. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, et al. (2006) H5N1 Virus Attachment to Lower Respiratory Tract. Science 312: 399.
15. Weinheimer VK, Becher A, Tonnies M, Holland G, Knepper J, et al. (2012) Influenza A Viruses Target Type II Pneumocytes in the Human Lung. J Infect Dis.
16. Subbarao EK, London W, Murphy BR, (1993) A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol 67: 1761-1764.
17. Massin P, van der Werf S, Naffakh N, (2001) Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. J Virol 75: 5398-5404.
18. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, et al. (2008) Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 358: 261-273.
19. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-1207.
20. Gao R, Dong L, Dong J, Wen L, Zhang Y, et al. (2010) A systematic molecular pathology study of a laboratory confirmed H5N1 human case. PLoS One 5: e13315.
21. Sirinonthanawech N, Uiprasertkul M, Suptawiwat O, Auewarakul P, (2011) Viral load of the highly pathogenic avian influenza H5N1 virus in infected human tissues. J Med Virol 83: 1418-1423.
22. Uiprasertkul M, Kitphati R, Puthavathana P, Kriwong R, Kongchanagul A, et al. (2007) Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis 13: 708-712.
23. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
24. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 997-1001.
25. Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, et al. (2007) IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9: 930-938.
26. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, et al. (1998) Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1: 507-518.
27. Platanias LC, (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5: 375-386.
28. Randall RE, Goodbourn S, (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1-47.
29. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, et al. (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252: 324-330.
30. Guo Z, Chen LM, Zeng H, Gomez JA, Plowden J, et al. (2007) NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 36: 263-269.
31. Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, et al. (2002) The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol 76: 11166-11171.
32. Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M Jr, et al. (2007) Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81: 514-524.
33. Talon J, Horvath CM, Polley R, Basler CF, Muster T, et al. (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74: 7989-7996.
34. Wang X, Li M, Zheng H, Muster T, Palese P, et al. (2000) Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74: 11566-11573.
35. Wolff T, Zielecki F, Abt M, Voss D, Semmler I, et al. (2008) Sabotage of antiviral signaling and effectors by influenza viruses. Biol Chem 389: 1299-1305.
36. Chan MC, Cheung CY, Chui WH, Tsao SW, Nicholls JM, et al. (2005) Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6: 135.
37. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, et al. (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360: 1831-1837.
38. Deng R, Lu M, Korteweg C, Gao Z, McNutt MA, et al. (2008) Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients. J Pathol 216: 328-336.
39. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, et al. (1998) Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351: 472-477.
40. Puthavathana P, Auewarakul P, Charoenying PC, Sangsiriwut K, Pooruk P, et al. (2005) Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. J Gen Virol 86: 423-433.
41. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR, (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146: 2275-2289.
42. Matrosovich M, Matrosovich T, Garten W, Klenk HD, (2006) New low-viscosity overlay medium for viral plaque assays. Virol J 3: 63.
43. Unterstab G, Ludwig S, Anton A, Planz O, Dauber B, et al. (2005) Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A 102: 13640-13645.
44. Terrier O, Moules V, Carron C, Cartet G, Frobert E, et al. (2012) The influenza fingerprints: NS1 and M1 proteins contribute to specific host cell ultrastructure signatures upon infection by different influenza A viruses. Virology 432: 204-218.
45. Kochs G, Koerner I, Thiel L, Kothlow S, Kaspers B, et al. (2007) Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol 88: 1403-1409.
46. Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, et al. (1988) Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A 85: 5259-5263.
47. Desmyter J, Melnick JL, Rawls WE, (1968) Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol 2: 955-961.
48. Wolff T, Ludwig S, (2009) Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences. J Interferon Cytokine Res 29: 549-557.
49. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
50. Jia D, Rahbar R, Chan RW, Lee SM, Chan MC, et al. (2010) Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling. PLoS One 5: e13927.
51. Lycett SJ, Ward MJ, Lewis FI, Poon AF, Kosakovsky Pond SL, et al. (2009) Detection of mammalian virulence determinants in highly pathogenic avian influenza H5N1 viruses: multivariate analysis of published data. J Virol 83: 9901-9910.
52. Bussey KA, Bousse TL, Desmet EA, Kim B, Takimoto T, (2010) PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. J Virol 84: 4395-4406.
53. Conenello GM, Tisoncik JR, Rosenzweig E, Varga ZT, Palese P, et al. (2011) A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. J Virol 85: 652-662.
54. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P, (2007) A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3: 1414-1421.
55. Long JX, Peng DX, Liu YL, Wu YT, Liu XF, (2008) Virulence of H5N1 avian influenza virus enhanced by a 15-nucleotide deletion in the viral nonstructural gene. Virus Genes 36: 471-478.
56. Twu KY, Kuo RL, Marklund J, Krug RM, (2007) The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol 81: 8112-8121.
57. Min JY, Li S, Sen GC, Krug RM, (2007) A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363: 236-243.
58. WHO (2012) In:Organisation WH, editor.
59. Govorkova EA, Rehg JE, Krauss S, Yen HL, Guan Y, et al. (2005) Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol 79: 2191-2198.
60. Le QM, Ito M, Muramoto Y, Hoang PV, Vuong CD, et al. (2010) Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam. J Gen Virol 91: 2485-2490.
61. Wang TT, Parides MK, Palese P, (2012) Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science 335: 1463.
62. Didcock L, Young DF, Goodbourn S, Randall RE, (1999) Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J Virol 73: 3125-3133.
63. Lee MH, Lalwani P, Raftery MJ, Matthaei M, Lutteke N, et al. (2011) RNA helicase retinoic acid-inducible gene I (RIG-I) as a sensor of Hantaan virus (HTNV) replication. J Gen Virol.
64. McFadden G, Mohamed MR, Rahman MM, Bartee E, (2009) Cytokine determinants of viral tropism. Nat Rev Immunol 9: 645-655.
65. Valmas C, Basler CF, (2011) Marburg virus VP40 antagonizes interferon signaling in a species-specific manner. J Virol 85: 4309-4317.
66. Wang F, Ma Y, Barrett JW, Gao X, Loh J, et al. (2004) Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier. Nat Immunol 5: 1266-1274.
67. Kugel D, Kochs G, Obojes K, Roth J, Kobinger GP, et al. (2009) Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets. J Virol 83: 3843-3851.
68. Szretter KJ, Gangappa S, Belser JA, Zeng H, Chen H, et al. (2009) Early control of H5N1 influenza virus replication by the type I interferon response in mice. J Virol 83: 5825-5834.
69. Van Hoeven N, Belser JA, Szretter KJ, Zeng H, Staeheli P, et al. (2009) Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. J Virol 83: 2851-2861.
70. Haasbach E, Droebner K, Vogel AB, Planz O, (2011) Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo. J Interferon Cytokine Res 31: 515-525.
71. Hayman A, Comely S, Lackenby A, Hartgroves LC, Goodbourn S, et al. (2007) NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response. J Virol 81: 2318-2327.
72. Ocana-Macchi M, Bel M, Guzylack-Piriou L, Ruggli N, Liniger M, et al. (2009) Hemagglutinin-dependent tropism of H5N1 avian influenza virus for human endothelial cells. J Virol 83: 12947-12955.
73. Geiler J, Michaelis M, Sithisarn P, Cinatl J Jr, (2011) Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Med Microbiol Immunol 200: 53-60.
74. Hayman A, Comely S, Lackenby A, Murphy S, McCauley J, et al. (2006) Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 347: 52-64.
75. Brennan K, Bowie AG, (2010) Activation of host pattern recognition receptors by viruses. Curr Opin Microbiol 13: 503-507.
76. Zhang Z, Kim T, Bao M, Facchinetti V, Jung SY, et al. (2011) DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 34: 866-878.
77. Hui KP, Lee SM, Cheung CY, Mao H, Lai AK, et al. (2011) H5N1 influenza virus-induced mediators upregulate RIG-I in uninfected cells by paracrine effects contributing to amplified cytokine cascades. J Infect Dis 204: 1866-1878.
78. Forbes NE, Ping J, Dankar SK, Jia JJ, Selman M, et al. (2012) Multifunctional adaptive NS1 mutations are selected upon human influenza virus evolution in the mouse. PLoS One 7: e31839.
79. Hatta M, Gao P, Halfmann P, Kawaoka Y, (2001) Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293: 1840-1842.
80. Jiao P, Tian G, Li Y, Deng G, Jiang Y, et al. (2008) A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol 82: 1146-1154.
81. Imai H, Shinya K, Takano R, Kiso M, Muramoto Y, et al. (2010) The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets. PLoS Pathog 6: e1001106.
82. Dankar SK, Wang S, Ping J, Forbes NE, Keleta L, et al. (2011) Influenza A virus NS1 gene mutations F103L and M106I increase replication and virulence. Virol J 8: 13.
83. Baum A, Sachidanandam R, Garcia-Sastre A, (2010) Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 107: 16303-16308.
84. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, et al. (2010) RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140: 397-408.
85. Wang Q, Zhang S, Jiang H, Wang J, Weng L, et al. (2012) PA from an H5N1 highly pathogenic avian influenza virus activates viral transcription and replication and induces apoptosis and interferon expression at an early stage of infection. Virol J 9: 106.
86. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, et al. (2005) The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A 102: 18590-18595.
87. Mehle A, Doudna JA, (2008) An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe 4: 111-122.
88. Bortz E, Westera L, Maamary J, Steel J, Albrecht RA, et al. (2011) Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins. MBio 2.
89. Robb NC, Smith M, Vreede FT, Fodor E, (2009) NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome. J Gen Virol 90: 1398-1407.
90. Manz B, Brunotte L, Reuther P, Schwemmle M, (2012) Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells. Nat Commun 3: 802.
91. Dudek SE, Wixler L, Nordhoff C, Nordmann A, Anhlan D, et al. (2011) The influenza virus PB1-F2 protein has interferon-antagonistic activity. Biol Chem.
92. Graef KM, Vreede FT, Lau YF, McCall AW, Carr SM, et al. (2010) The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol 84: 8433-8445.
93. Iwai A, Shiozaki T, Kawai T, Akira S, Kawaoka Y, et al. (2010) Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem 285: 32064-32074.
94. Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, et al. (2011) The influenza virus protein PB1-F2 inhibits the induction of type i interferon at the level of the MAVS adaptor protein. PLoS Pathog 7: e1002067.
95. Wu WL, Chen Y, Wang P, Song W, Lau SY, et al. (2008) Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol 82: 1798-1807.
96. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, et al. (2008) The influenza virus resource at the National Center for Biotechnology Information. J Virol 82: 596-601.
97. He X, Zhou J, Bartlam M, Zhang R, Ma J, et al. (2008) Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus. Nature 454: 1123-1126.
98. Regan JF, Liang Y, Parslow TG, (2006) Defective assembly of influenza A virus due to a mutation in the polymerase subunit PA. J Virol 80: 252-261.
99. Le QM, Sakai-Tagawa Y, Ozawa M, Ito M, Kawaoka Y, (2009) Selection of H5N1 influenza virus PB2 during replication in humans. J Virol 83: 5278-5281.
100. Pepin KM, Lass S, Pulliam JR, Read AF, Lloyd-Smith JO, (2010) Identifying genetic markers of adaptation for surveillance of viral host jumps. Nat Rev Microbiol 8: 802-813.
101. Fukuyama S, Kawaoka Y, (2011) The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol 23: 481-486.